Company Info






  Home > Archived Webinars >

Uniting Corporate Philanthropy and Advocacy Relations to Maximize Impact and Corporate Reputation
Uniting Corporate Philanthropy and Advocacy Relations to Maximize Impact and Corporate Reputation


 
Our Price: $395.00

Product Code: WB-7091
Qty:

Product Info
 
About the Product
Includes 40 minute Windows Media Video File and PowerPoint presentations for immediate download.


Bio Pharma corporate reputation is vital to drive business objectives; 80-90% of a company’s value may lie in intangibles like reputation. Fighting and preventing diseases requires more than developing drugs; it necessitates multi-stakeholder engagement from “bench to bedside” to facilitate advancement of the science and improve patient health outcomes. Advocacy relations and public policy strategies have increasingly focused on building corporate reputation through collaborations aligned with business objectives. Many bio pharma companies also engage in corporate philanthropy efforts that support underserved local communities in areas of need. Bio pharma companies have faced increasing public scrutiny due to lack of transparency surrounding the corporate motives for specific funding initiatives. A multidimensional, harmonized strategy must align corporate communications, advocacy relations and public policy, and corporate philanthropy in order to deliver a measurable impact on reputation and mitigate external scrutiny. The objectives of this program are to:
  • Provide an overview of drivers of corporate reputation
  • Discuss a framework to align the mutual benefits of engagement between manufacturers and philanthropic organizations
  • Manage risks through disclosure and compliance

Speaker:

Jill Dolgin, PharmD
Senior Director, Global Head Patient Advocacy and Public Policy
Insmed Incorporated


Participants that will find this webinar most beneficial will be those involved in pharmaceutical and biotechnology companies. Job titles of attendees that will be most applicable for this session will be:
  • Patient Advocacy
  • Philanthropy and Social Responsibility
  • Public Policy and Government Affairs
  • Professional Relations
  • Corporate Communications


Share your knowledge of this product. Be the first to write a review »